Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEETINGS - Brand communication in the marketing mix (Germany) June 2005:

This article was originally published in Clinica

Executive Summary

Brand communication and the role of PR in the marketing mix are the themes of a BVMed/MedInform congress in Frankfurt, Germany, on June 7 2005. These can be crucial success factors in times of more selective healthcare system funding, and product upgrades and innovations need to be better and more proactively communicated to the public and healthcare funding decision-makers. To get this message over more effectively to what is anyway an increasingly educated patient population, medtech companies need to tailor their communications better. "Kommunkationskongress Medizintechnologie" will be addressed by branding, marketing and communications specialists from Paul Hartmann, Otto Bock, Mummert and Boehringer Ingelheim, among others. For details, contact: BVMed in Berlin on tel: +49 30 246 255-20: www.bvmed.de

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel